Table 1.
The summary of essential oils from different plants, their pharmacological properties, and mechanism of actions.
| EO Botanical Origins | Administration | Pharmacological Effects | Mechanism of Actions | Authors/Year/Ref. |
|---|---|---|---|---|
| Achillea Wilhelmsii C. Koch | i.p. | anxiolytic effects | not probably mediated through GABA and opioid receptors | Majnooni et al., 2013 [19] |
| Acorus gramineus Rhizoma | INH; p.o. | pentylenetetrazole-induced convulsion; sedative effect; CNS inhibitory effects | increased GABA level; decreased GABA transaminase | Koo et al., 2003 [20] |
| Acorus tatarinowii Schott | analgesic effects | inhibited Na+ channels | Moreira-Lobo et al., 2010 [17] | |
| Aloysia citrodora Palau | in vitro | effective antioxidant, radical-scavenging activities, and neuronal protection | inhibited [3H] nicotine binding | Abuhamdah et al., 2015 [21] |
| Artemisia herba-alba | in vitro | antifungal and anti-inflammatory activities | N/A | Abu-Darwish et al., 2015 [22] |
| Artemisia ludoviciana | i.p. | antinociceptive activity | partially mediated by the opioid system | Anaya-Eugenio et al., 2016 [23] |
| Artemisia judaica | in vitro | antifungal and anti-inflammatory activities | N/A | Abu-Darwish et al., 2016 [24] |
| Artemisia dracunculus | i.p. | peripheral and central antinociceptive activity | N/A | Maham et al., 2014 [25] |
| Asarum heterotropoides | INH | decreased depression-like behaviors | N/A | Park et al., 2015 [26] |
| Camellia sinensis | INH | increased sleeping time | potentiated GABAA receptors | Hossain et al., 2004 [27] |
| Citrus aurantium | p.o. | anxiolyticlike activity | serotonergic system (5-HT1A receptors) | Costa et al., 2013 [28] |
| Citrus bergamia | decreased stress-induced anxiety | tuning synaptic plasticity | Bagetta et al., 2010 [29] | |
| Citrus sinensis | INH | acute anxiolytic activity | N/A | Faturi et al., 2010 [30] |
| Coriander | INH | increased anxiolytic–antidepressant-like behaviors, and | N/A | Cioanca et al., 2014 [31] |
| Cymbopogon citratus | p.o. | anxiolytic-like activity | potentiated GABAA receptor complex | Costa et al., 2011 [13] |
| Cymbopogon winterianus Jowitt; and C. citratus (DC) Stapf. | i.p. | anticonvulsant activities | via GABAergic neurotransmission | Silva et al., 2010 [32] |
| Dysphania graveolens | p.o. | antinociceptive effects | N/A | Déciga-Campos et al., 2017 [33] |
| Hyptis mutabilis (Rich.) Briq. | p.o. | sedative and central anesthetic activities | no involvement of the GABAA-BDZ system | Silva et al., 2013 [34] |
| Lavandula angustifolia | INH | anxiolytic-like effects | serotonergic system | Chioca et al., 2013 [35] |
| Lippia alba (Mill.) N.E. Brown | p.o. | central anesthetic effect | involvement of the GABAergic system | Heldwein et al., 2012 [36] |
| Lemon oil | anxiolytic, antidepressant-like effects | suppression of DA activity related to enhanced 5-HTnergic neurons | Komiya et al., 2006 [37] | |
| Melissa officinalis | p.o. | anti-agitation effects in patients and the depressant effects in in-vitro | inhibited GABA-induced currents | Abuhamdah et al., 2008 [38] |
| Nigella sativa Seed lmain components | p.o. | potentiation of valproate-induced anticonvulsant effect | increased in GABAergic response | Raza et al., 2008 [39] |
| Perfume and phytoncid | in vitro | anxiolytic anticonvulsant and sedative activity | potentiating GABAA receptors | Aoshima and Hamamoto, 1999 [40] |
| Piper guineense | INH | sedative and anxiolytic-like effects | N/A | Tankam and Tto, 2013 [2] |
| Pistacia integerrima Stewart ex Brandis Galls | in vitro | relaxant and spasmolytic effects | involvement of β-adrenoceptors and calcium channels | Shirole et al., 2015 [41] |
| Salvia sclarea | i.p. or INH | anti-depressant-like effect | modulating DAnergic pathway | Seol et al., 2010 [42] |
| Syzygium aromaticum | local anesthesia | Inhibited sodium channels | Huang et al., 2012 [43] | |
| Tagetes minuta L | sc | anxiogenic-like effects | negative modulation on the GABAergic function | Marin et al., 1998 [44] |
| Thymus capitatus Hoff. et Link. | p.o. | antinociceptive activity | via peripheral nervous excitability blockade | Gonçalves et al., 2017 [45] |
| Valerian officinalis L | p.o. | sedatives | N/A | Houghton, 1999 [46] |
Note: N/A: not applicable; p.o.: by mouth, oral; sc: subcutaneous injection; i.p.: intraperitoneal injection; INH: inhalation.